CAS 2226507-04-4

Formel: C20H24N6

InChl: InChI=1S/C20H24N6/c1-2-8-25-20(6-1)7-3-11-26(13-20)17-5-10-22-19-18(17)15(12-23-19)16-4-9-21-14-24-16/h4-5,9-10,12,14,25H,1-3,6-8,11,13H2,(H,22,23)/t20-/m0/s1

InChI Key: UELSMLDRSQFVHG-FQEVSTJZSA-N

SMILES: C1CCN[C@@]2(C1)CCCN(C2)C3=C4C(=CNC4=NC=C3)C5=NC=NC=C5

BDP9066

CAS: 2226507-04-4

BDP9066

Formel: C₂₀H₂₄N₆

Reinheit: ≥98%

Molekulargewicht: 348.44

Ref: 54-BUP09031

BDP9066

CAS: 2226507-04-4

Formel: C₂₀H₂₄N₆

Molekulargewicht: 348.4448

Ref: IN-DA01V6ZX

BDP9066

CAS: 2226507-04-4

Formel: C₂₀H₂₄N₆

Molekulargewicht: 348.45

Ref: 4Z-B-242001

BDP9066

CAS: 2226507-04-4

Formel: C₂₀H₂₄N₆

Molekulargewicht: 348.4

Ref: BE-RMCB025000

BPD 9066

CAS: 2226507-04-4

BPD 9066 is a small-molecule inhibitor of the DNA methyltransferase enzyme, which is involved in gene expression profiles. BPD 9066 has been shown to have anti-cancer effects in mice with alveolar cell carcinoma. This drug also has an effect on muscle cells by preventing them from converting carbon sources into energy, which may be due to its ability to inhibit the activity of xylan synthase. BPD 9066 also inhibits the growth and proliferation of human papillomavirus (HPV), but does not affect the virus's infectivity.

Formel: C₂₀H₂₄N₆

Reinheit: Min. 95%

Molekulargewicht: 348.45 g/mol

Ref: 3D-BB168607

BDP9066

CAS: 2226507-04-4

BDP9066 is a potent and selective MRCK inhibitor, inhibits MRCKβ and MRCKα/β, and can be used for the prevention and treatment of skin cancer.

Formel: C₂₀H₂₄N₆

Reinheit: 98.18%

Farbe und Form: White Solid

Molekulargewicht: 348.4448

Ref: TM-T14521